The authors established cells with acquired resistance to the allosteric SHP2 inhibitor SHP099 from two FLT3-ITD-positive AML cell lines.
[Cancer Research]
Sorry, but the selected Zotpress account can't be found.
Sorry, but the selected Zotpress account can't be found.